PDGFRB and nonpapillary renal cell carcinoma: By promoting platelet-derived growth factor β (PDGFRβ) transcription through H3 K18 la, the inactivation of VHL, a key prognostic factor in ccRCC, creates a positive feedback loop that accelerates the development of ccRCC [97].